Ravindran Balambal Palaniyandi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7139 North Highway Us # 1, Port St John, FL 32927 Phone: 321-635-8304 Fax: 321-635-8252 |
News Archive
In this paper published in the Journal of the International AIDS Society, researchers from South Africa, Namibia, Brazil, and the U.S. "explore the existing evidence related to global and country-specific barriers to safe abortion for all women, with an emphasis on research gaps around the right of women living with HIV to choose safe abortion services as an option for dealing with unwanted pregnancies."
When new AIDS virus particles bud from an infected cell, an enzyme named protease activates to help the viruses mature and infect more cells. That's why modern AIDS drugs control the disease by inhibiting protease.
Democratic Senators Mary Landrieu, Blanche Lincoln and Debbie Stabenow joined Terry Gardiner of the Small Business Majority and Mike Brey, small business owner from Maryland, at a press conference this afternoon to unveil a package of amendments to The Patient Protection and Affordable Care Act that will benefit small businesses.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
"A growing number of countries are adopting India's intellectual property regulations, which give enough flexibility to local companies to produce generic versions of popular drugs to safeguard public health," India's Economic Times reports, noting, "In March, India issued the country's first compulsory license, allowing Natco Pharma to legally manufacture and sell a low-cost version of German drugmaker Bayer AG's patented cancer drug, Nexavar, at 3 percent of the original medicine's price on the grounds that Bayer's drug was not meeting public health requirement."
› Verified 8 days ago